KORNITZER CAPITAL MANAGEMENT INC /KS - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
KORNITZER CAPITAL MANAGEMENT INC /KS ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$3,537,000
-6.0%
106,899
-0.5%
0.06%
-8.8%
Q1 2019$3,764,000
+5.4%
107,424
-0.1%
0.07%
-4.2%
Q4 2018$3,571,000
-52.7%
107,509
-28.2%
0.07%
-40.8%
Q3 2018$7,542,000
-15.6%
149,785
+0.3%
0.12%
-20.0%
Q2 2018$8,939,000
-14.0%
149,360
-34.2%
0.15%
-15.7%
Q1 2018$10,396,000
+5.4%
226,980
-8.3%
0.18%
+6.0%
Q4 2017$9,867,000
-7.4%
247,605
-7.0%
0.17%
-9.7%
Q3 2017$10,651,000
-26.6%
266,265
-20.9%
0.19%
-26.8%
Q2 2017$14,515,000
+15.2%
336,765
-16.3%
0.25%
+13.4%
Q1 2017$12,596,000
+24.0%
402,4350.0%0.22%
+17.9%
Q4 2016$10,161,000
-45.8%
402,435
-47.0%
0.19%
-43.6%
Q3 2016$18,763,000
+10.0%
758,705
-9.4%
0.34%
+9.1%
Q2 2016$17,052,000
+43.2%
837,125
+7.2%
0.31%
+50.7%
Q1 2016$11,906,000
-28.9%
780,715
-37.3%
0.20%
-25.2%
Q4 2015$16,735,000
+43.2%
1,245,170
+49.5%
0.27%
+47.3%
Q3 2015$11,685,000832,8900.19%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders